AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 21464451 — intervention group
Group type: COMPARATOR
Intervention: Untreated group
Number of subjects: 18
Study 19589290 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal flunisolide
Number of subjects: 178
Study 19589290 — intervention group
Group type: COMPARATOR
Intervention: Isotonic saline solution
Number of subjects: 178
Study 16916809 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone counselling by a pharmacist
Number of subjects: 502
Study 16916809 — intervention group
Group type: COMPARATOR
Intervention: Control group (no telephone counselling)
Number of subjects: 502
Study 16916809 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall cohort analysis
Number of subjects: 502
Study 15593188 — intervention group
Group type: EXPERIMENTAL
Intervention: Bosentan
Number of subjects: 122
Study 15593188 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 122
Study 11333074 — intervention group
Group type: EXPERIMENTAL
Intervention: High reactivity and high reliance on mother during emotion challenges
Number of subjects: 518
Study 11333074 — intervention group
Group type: EXPERIMENTAL
Intervention: High fearful distress and low reliance on mother
Number of subjects: 518
Study 9149585 — intervention group
Group type: EXPERIMENTAL
Intervention: Normothermic (warm) technique
Number of subjects: 331
Study 9149585 — intervention group
Group type: COMPARATOR
Intervention: Hypothermic (cold) technique
Number of subjects: 331
Study 7898968 — intervention group
Group type: EXPERIMENTAL
Intervention: End-inspiratory occlusion (TGVl)
Number of subjects: 15
Study 7898968 — intervention group
Group type: COMPARATOR
Intervention: End-expiratory occlusion (TGVE)
Number of subjects: 15
Study 7898968 — intervention group
Group type: EXPERIMENTAL
Intervention: Airway resistance (R(aw))
Number of subjects: 15
Study 2646255 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiotherapy plus misonidazole (RT + MISO)
Number of subjects: 40
Study 2646255 — intervention group
Group type: COMPARATOR
Intervention: Radiotherapy only (RT)
Number of subjects: 40
Study 5774077 — intervention group
Group type: EXPERIMENTAL
Intervention: New technique of ascending functional cinephlebography
Number of subjects: 22
Study 5774077 — intervention group
Group type: COMPARATOR
Intervention: Delayed diagnosis
Number of subjects: 22
Study 31165717 — intervention group
Group type: EXPERIMENTAL
Intervention: SmokefreeTXT (SMS text messaging service)
Number of subjects: 50
Study 31165717 — intervention group
Group type: COMPARATOR
Intervention: Control (no SMS text messaging service)
Number of subjects: 50
Study 31165717 — intervention group
Group type: EXPERIMENTAL
Intervention: SmokefreeTXT
Number of subjects: 50
Study 28506003 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral EMG-triggered multi-channel electrostimulation + mirror therapy
Number of subjects: 33
Study 28506003 — intervention group
Group type: COMPARATOR
Intervention: Bilateral EMG-triggered multi-channel electrostimulation
Number of subjects: 33
Study 25623822 — intervention group
Group type: EXPERIMENTAL
Intervention: Bereavement follow-up intervention
Number of subjects: 136
Study 25623822 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 136
Study 25623822 — intervention group
Group type: EXPERIMENTAL
Intervention: Greater support from healthcare professionals
Number of subjects: 136
Study 25623822 — intervention group
Group type: EXPERIMENTAL
Intervention: Mothers' age, self-perceived health status, and age of deceased child
Number of subjects: 136
Study 23506170 — intervention group
Group type: EXPERIMENTAL
Intervention: Insecticide-treated nets (ITNs) distributed to treatment group households
Number of subjects: 39963
Study 21439047 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored implementation programme for CHF management
Number of subjects: 60
Study 21439047 — intervention group
Group type: COMPARATOR
Intervention: Standardised way of delivering the programme
Number of subjects: 60
Study 18535605 — intervention group
Group type: EXPERIMENTAL
Intervention: Bimatoprost/timolol fixed combination (BTFC)
Number of subjects: 54
Study 18535605 — intervention group
Group type: COMPARATOR
Intervention: Latanoprost/timolol fixed combination (LTFC)
Number of subjects: 54
Study 18535605 — intervention group
Group type: COMPARATOR
Intervention: LTFC
Number of subjects: 54
Study 16420196 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonpharmacological intervention including daytime physical activity, evening bright light exposure, consistent bedtime routine, nighttime care routines, strategies to reduce nighttime noise.
Number of subjects: 273
Study 16420196 — intervention group
Group type: COMPARATOR
Intervention: Control group (Group 2) received no intervention initially.
Number of subjects: 273
Study 16420196 — intervention group
Group type: EXPERIMENTAL
Intervention: Polysomnography in a subgroup of 45 subjects.
Number of subjects: 273
Study 15279042 — intervention group
Group type: EXPERIMENTAL
Intervention: Clozapine
Number of subjects: 227
Study 15279042 — intervention group
Group type: COMPARATOR
Intervention: First generation antipsychotic medications
Number of subjects: 227
Study 11225716 — intervention group
Group type: EXPERIMENTAL
Intervention: Obese patients without OSAS
Number of subjects: 25
Study 11225716 — intervention group
Group type: EXPERIMENTAL
Intervention: Obese patients with OSAS
Number of subjects: 25
Study 11225716 — intervention group
Group type: EXPERIMENTAL
Intervention: Obese patients with OHS
Number of subjects: 25
Study 11225716 — intervention group
Group type: COMPARATOR
Intervention: Control group (healthy women)
Number of subjects: 25
Study 8843207 — intervention group
Group type: EXPERIMENTAL
Intervention: Nevirapine at doses > or = 240 mg/m2/day
Number of subjects: 21
Study 8843207 — intervention group
Group type: EXPERIMENTAL
Intervention: Nevirapine
Number of subjects: 21
Study 1292918 — intervention group
Group type: EXPERIMENTAL
Intervention: L-carnitine (4 g/day for 12 months)
Number of subjects: 160
Study 1292918 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 160
Study 6828970 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 gram intravenous bolus dose of cefamandole
Number of subjects: 102
Study 6828970 — intervention group
Group type: COMPARATOR
Intervention: Control group (no cefamandole)
Number of subjects: 102
Study 31177391 — intervention group
Group type: EXPERIMENTAL
Intervention: HERMES intervention
Number of subjects: 199
Study 31177391 — intervention group
Group type: COMPARATOR
Intervention: Control group (delayed intervention)
Number of subjects: 199
Study 30418963 — intervention group
Group type: EXPERIMENTAL
Intervention: Exclusive double poling (DP)
Number of subjects: 19
Study 30418963 — intervention group
Group type: COMPARATOR
Intervention: Classic techniques (CLASSIC)
Number of subjects: 19
Study 29259310 — intervention group
Group type: EXPERIMENTAL
Intervention: rhIL-2 injection
Number of subjects: 271
Study 26586249 — intervention group
Group type: EXPERIMENTAL
Intervention: Responses to 34 questions on a 5-point Likert scale regarding barriers to following the hemodialysis diet
Number of subjects: 140
Study 26586249 — intervention group
Group type: EXPERIMENTAL
Intervention: Duration of hemodialysis
Number of subjects: 140
Study 24955674 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-delivered, home-based, alcohol-specific attention modification program (AMP)
Number of subjects: 41
Study 24955674 — intervention group
Group type: COMPARATOR
Intervention: Attention control condition (ACC)
Number of subjects: 41
Study 22965960 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine
Number of subjects: 185
Study 22965960 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 185
Study 20190918 — intervention group
Group type: EXPERIMENTAL
Intervention: Information phase for 5 nursing staff
Number of subjects: 6
Study 20190918 — intervention group
Group type: EXPERIMENTAL
Intervention: Video scoring phase for all 6 nursing staff
Number of subjects: 6
Study 20190918 — intervention group
Group type: EXPERIMENTAL
Intervention: Safety feedback phase for 2 participants
Number of subjects: 6
Study 20190918 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment withdrawal for all participants
Number of subjects: 6
Study 17721095 — intervention group
Group type: EXPERIMENTAL
Intervention: Memantine (10 mg daily escalated to 40 mg daily for 16 weeks)
Number of subjects: 140
Study 17721095 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 140
Study 15513282 — intervention group
Group type: COMPARATOR
Intervention: Triathletes
Number of subjects: 48
Study 15513282 — intervention group
Group type: COMPARATOR
Intervention: Swimmers
Number of subjects: 48
Study 15513282 — intervention group
Group type: COMPARATOR
Intervention: Cyclists
Number of subjects: 48
Study 15513282 — intervention group
Group type: COMPARATOR
Intervention: Controls
Number of subjects: 48
Study 11241253 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium supplementation (3.75 g calcium carbonate daily)
Number of subjects: 52
Study 11241253 — intervention group
Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 52
Study 9558016 — intervention group
Group type: EXPERIMENTAL
Intervention: Protocol B (120 min/wk, 20 min x 2 per day, 3 days/wk)
Number of subjects: 24
Study 9558016 — intervention group
Group type: EXPERIMENTAL
Intervention: Protocol C (120 min/wk, 20 min/day, 6 days/wk)
Number of subjects: 24
Study 9558016 — intervention group
Group type: COMPARATOR
Intervention: Protocol A (20 min/wk, 10 min/day, 2 days/wk)
Number of subjects: 24
Study 8299916 — intervention group
Group type: EXPERIMENTAL
Intervention: Methotrexate
Number of subjects: 24
Study 8299916 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 2543895 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal estradiol (Estraderm)
Number of subjects: 0
Study 29877724 — intervention group
Group type: EXPERIMENTAL
Intervention: Trauma-Focused Cognitive Behavioral Therapy (TF-CBT)
Number of subjects: 156
Study 29877724 — intervention group
Group type: COMPARATOR
Intervention: Therapy as Usual (TAU)
Number of subjects: 156
Study 28591133 — intervention group
Group type: EXPERIMENTAL
Intervention: bioavailable RC extract (RCE), providing 34 mg/d isoflavones and probiotics
Number of subjects: 62
Study 28591133 — intervention group
Group type: COMPARATOR
Intervention: masked placebo formulation
Number of subjects: 62
Study 25053650 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief computerized reasoning training intervention
Number of subjects: 101
Study 25053650 — intervention group
Group type: COMPARATOR
Intervention: Control condition involving computer‐based activities of similar duration
Number of subjects: 101
Study 23661240 — intervention group
Group type: EXPERIMENTAL
Intervention: PTHrP(1-36) 400 µg/day
Number of subjects: 105
Study 23661240 — intervention group
Group type: EXPERIMENTAL
Intervention: PTHrP(1-36) 600 µg/day
Number of subjects: 105
Study 23661240 — intervention group
Group type: EXPERIMENTAL
Intervention: PTH(1-34) 20 µg/day
Number of subjects: 105
Study 21764469 — intervention group
Group type: EXPERIMENTAL
Intervention: Ivabradine up to 7.5mg bid
Number of subjects: 121
Study 21764469 — intervention group
Group type: EXPERIMENTAL
Intervention: Carvedilol/ivabradine up to 12.5/7.5mg bid
Number of subjects: 121
Study 21764469 — intervention group
Group type: COMPARATOR
Intervention: Carvedilol up to 25mg bid
Number of subjects: 121
Study 19716510 — intervention group
Group type: EXPERIMENTAL
Intervention: GuttaFlow
Number of subjects: 30
Study 19716510 — intervention group
Group type: EXPERIMENTAL
Intervention: Sealapex
Number of subjects: 30
Study 19716510 — intervention group
Group type: EXPERIMENTAL
Intervention: Sealer 26
Number of subjects: 30
Study 16943456 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fat meal (HF)
Number of subjects: 49
Study 16943456 — intervention group
Group type: COMPARATOR
Intervention: Low-fat meal (LF)
Number of subjects: 49
Study 12505481 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucosamine sulfate
Number of subjects: 212
Study 12505481 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 212
Study 10917292 — intervention group
Group type: EXPERIMENTAL
Intervention: PICC catheter
Number of subjects: 63
Study 10917292 — intervention group
Group type: COMPARATOR
Intervention: PIV catheter
Number of subjects: 63
Study 9431774 — intervention group
Group type: EXPERIMENTAL
Intervention: Xomed Audiant Bone Conductor
Number of subjects: 0
Study 9431774 — intervention group
Group type: COMPARATOR
Intervention: NobleBiocare HC200 bone‐anchored hearing aid (BAHA) implant
Number of subjects: 0
Study 1559296 — intervention group
Group type: EXPERIMENTAL
Intervention: Levothyroxine (mean dose 2.82 +/- 0.6 micrograms/kg/day)
Number of subjects: 40
Study 1559296 — intervention group
Group type: COMPARATOR
Intervention: Control group (no levothyroxine)
Number of subjects: 40
Study 3891826 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketotifen
Number of subjects: 18
Study 3891826 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 31715140 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiuser virtual reality (MU) therapy
Number of subjects: 20
Study 31715140 — intervention group
Group type: COMPARATOR
Intervention: Single-user virtual reality (SU) therapy
Number of subjects: 20
Study 31715140 — intervention group
Group type: EXPERIMENTAL
Intervention: Both MU and SU therapy
Number of subjects: 20
Study 28277921 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone (3 IM doses of 8 mg, 8 hours apart)
Number of subjects: 1272
Study 28277921 — intervention group
Group type: COMPARATOR
Intervention: Control (no dexamethasone)
Number of subjects: 1272
Study 27806033 — intervention group
Group type: EXPERIMENTAL
Intervention: Arthrem® (ART) 150 mg twice-daily
Number of subjects: 34
Study 27806033 — intervention group
Group type: EXPERIMENTAL
Intervention: Arthrem® (ART)
Number of subjects: 34
Study 24493730 — intervention group
Group type: EXPERIMENTAL
Intervention: XRT group (postoperative radiotherapy)
Number of subjects: 381
Study 24493730 — intervention group
Group type: COMPARATOR
Intervention: non‐XRT group (no postoperative radiotherapy)
Number of subjects: 381
Study 23295170 — intervention group
Group type: EXPERIMENTAL
Intervention: Monetary incentives ranging from $10 to $38.75 for meeting fitness-center use goals
Number of subjects: 117
Study 23295170 — intervention group
Group type: COMPARATOR
Intervention: No treatment (control condition)
Number of subjects: 117
Study 23295170 — intervention group
Group type: EXPERIMENTAL
Intervention: Monetary incentives
Number of subjects: 117
Study 21358208 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly docetaxel (35 mg/m2, days 1, 8, and 15; q4w)
Number of subjects: 242
Study 21358208 — intervention group
Group type: COMPARATOR
Intervention: Standard docetaxel (75 mg/m2 every 3 weeks; q3w)
Number of subjects: 242
Study 21358208 — intervention group
Group type: COMPARATOR
Intervention: Standard arm (q3w)
Number of subjects: 242
Study 21358208 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly arm (q1w)
Number of subjects: 242
Study 18782780 — intervention group
Group type: EXPERIMENTAL
Intervention: enfuvirtide+HAART
Number of subjects: 47
Study 18782780 — intervention group
Group type: COMPARATOR
Intervention: HAART
Number of subjects: 47
Study 18782780 — intervention group
Group type: EXPERIMENTAL
Intervention: enfuvirtide+HAART (maintenance phase)
Number of subjects: 47
Study 18782780 — intervention group
Group type: COMPARATOR
Intervention: HAART (maintenance phase)
Number of subjects: 47
Study 18782780 — intervention group
Group type: EXPERIMENTAL
Intervention: enfuvirtide+HAART continuation arm
Number of subjects: 47
Study 18782780 — intervention group
Group type: EXPERIMENTAL
Intervention: enfuvirtide discontinuation arm
Number of subjects: 47
Study 18782780 — intervention group
Group type: COMPARATOR
Intervention: HAART arm
Number of subjects: 47
Study 16815485 — intervention group
Group type: EXPERIMENTAL
Intervention: Arginine-supplemented diet (AG; n = 14)
Number of subjects: 28
Study 16815485 — intervention group
Group type: COMPARATOR
Intervention: Isocaloric isonitrogenous diet (CG; n = 14)
Number of subjects: 28
Study 14531537 — intervention group
Group type: EXPERIMENTAL
Intervention: Cholecystectomy
Number of subjects: 64
Study 14531537 — intervention group
Group type: COMPARATOR
Intervention: Observation
Number of subjects: 64
Study 10673875 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam 0.05 mg kg‐1 i.v. (group TM)
Number of subjects: 25
Study 10673875 — intervention group
Group type: COMPARATOR
Intervention: No midazolam (group T0)
Number of subjects: 25
Study 10673875 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam premedication
Number of subjects: 25
Study 8535649 — intervention group
Group type: EXPERIMENTAL
Intervention: Methotrexate (MTX)
Number of subjects: 0
Study 2405883 — intervention group
Group type: EXPERIMENTAL
Intervention: labetalol
Number of subjects: 27
Study 2405883 — intervention group
Group type: COMPARATOR
Intervention: atenolol
Number of subjects: 27
Study 7353128 — intervention group
Group type: EXPERIMENTAL
Intervention: Dextran 70
Number of subjects: 3984
Study 7353128 — intervention group
Group type: COMPARATOR
Intervention: Low-dose heparin
Number of subjects: 3984
Study 31233409 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol with dexmedetomidine (0.3 μg/kg)
Number of subjects: 101
Study 31233409 — intervention group
Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 101
Study 31233409 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol with dexmedetomidine
Number of subjects: 101
Study 31233409 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 101
Study 28276946 — intervention group
Group type: EXPERIMENTAL
Intervention: Humorous story line about unprotected sex
Number of subjects: 161
Study 28276946 — intervention group
Group type: COMPARATOR
Intervention: Identical story line with humor edited out
Number of subjects: 161
Study 28276946 — intervention group
Group type: COMPARATOR
Intervention: Story line unrelated to unprotected sex
Number of subjects: 161
Study 25139667 — intervention group
Group type: EXPERIMENTAL
Intervention: Adalimumab plus methotrexate
Number of subjects: 1467
Study 24171019 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium enriched mixture (CEM)
Number of subjects: 42
Study 24171019 — intervention group
Group type: EXPERIMENTAL
Intervention: ProRoot mineral trioxide aggregate (MTA)
Number of subjects: 42
Study 21562425 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 mg intranasal nicotine
Number of subjects: 179
Study 19229791 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-body MRI (WB-MRI)
Number of subjects: 213
Study 19229791 — intervention group
Group type: COMPARATOR
Intervention: Bone Scintigraphy (BS)
Number of subjects: 213
Study 16846536 — intervention group
Group type: EXPERIMENTAL
Intervention: Topiramate 50 mg/day
Number of subjects: 469
Study 16846536 — intervention group
Group type: EXPERIMENTAL
Intervention: Topiramate 100 mg/day
Number of subjects: 469
Study 16846536 — intervention group
Group type: EXPERIMENTAL
Intervention: Topiramate 200 mg/day
Number of subjects: 469
Study 16846536 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 469
Study 12759322 — intervention group
Group type: EXPERIMENTAL
Intervention: Strength training group (high-intensity isometric neck strengthening and stabilization exercises with an elastic band)
Number of subjects: 180
Study 12759322 — intervention group
Group type: EXPERIMENTAL
Intervention: Endurance training group (dynamic neck exercises including lifting the head up from supine and prone positions)
Number of subjects: 180
Study 12759322 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention)
Number of subjects: 180
Study 12759322 — intervention group
Group type: EXPERIMENTAL
Intervention: Both training groups (strength and endurance)
Number of subjects: 180
Study 12759322 — intervention group
Group type: EXPERIMENTAL
Intervention: Strength training group
Number of subjects: 180
Study 12759322 — intervention group
Group type: EXPERIMENTAL
Intervention: Endurance training group
Number of subjects: 180
Study 11758634 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetaminophen 40 mg/kg
Number of subjects: 62
Study 11758634 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetaminophen 100 mg/kg
Number of subjects: 62
Study 11758634 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 62
Study 9586749 — intervention group
Group type: EXPERIMENTAL
Intervention: Entrance high contrast binocular acuity
Number of subjects: 134
Study 9586749 — intervention group
Group type: EXPERIMENTAL
Intervention: Best corrected low contrast monocular acuity
Number of subjects: 134
Study 9586749 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual acuity score at Repeat Visit
Number of subjects: 134
Study 9586749 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraclass correlation coefficients
Number of subjects: 134
Study 7795014 — intervention group
Group type: EXPERIMENTAL
Intervention: Awareness program (video discussion)
Number of subjects: 124
Study 7795014 — intervention group
Group type: COMPARATOR
Intervention: Control group (no discussion)
Number of subjects: 124
Study 2492011 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta- and gamma-interferon combination therapy
Number of subjects: 20
Study 2492011 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 20
Study 235939 — intervention group
Group type: EXPERIMENTAL
Intervention: Ritodrine treatment
Number of subjects: 63
Study 235939 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 63
Study 235939 — intervention group
Group type: EXPERIMENTAL
Intervention: Infants weighing less than 2300 grams
Number of subjects: 63
Study 7357339 — intervention group
Group type: EXPERIMENTAL
Intervention: Metronidazole in patients with normal or inflamed appendix (n=96)
Number of subjects: 263
Study 7357339 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=91)
Number of subjects: 263
Study 7357339 — intervention group
Group type: EXPERIMENTAL
Intervention: Ampicillin in patients with gangrenous or perforated appendices (n=32)
Number of subjects: 263
Study 7357339 — intervention group
Group type: EXPERIMENTAL
Intervention: Metronidazole in patients with gangrenous or perforated appendices (n=31)
Number of subjects: 263
Study 31490321 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention worksites
Number of subjects: 63
Study 31490321 — intervention group
Group type: COMPARATOR
Intervention: Control worksites
Number of subjects: 63
Study 29270789 — intervention group
Group type: EXPERIMENTAL
Intervention: ImpACT (SoC plus four individual and three group sessions)
Number of subjects: 64
Study 29270789 — intervention group
Group type: COMPARATOR
Intervention: Standard of Care (SoC: three adherence counseling sessions)
Number of subjects: 64